ASX debutant aims to revolutionise prenatal screening
Identifai's testing platform can assess fetal risk across more than 280 clinically actionable genes. Photo: Jane Dempster/AAP PHOTOS An Israeli company aiming to harness artificial intelligence to screen unborn babies for hundreds of genetic …